Overview
Investment Type
Venture Capital
Portfolio 1
| Date | Name | Website | Total Raised | Location |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 14, 2011 | Avraham Pharmaceuticals Closes $3M Financing | Avraham Pharmaceuticals Ltd., an Israeli developer of a novel molecule for treatment of Alzheimer’s disease, mild cognitive impairment and other neurodegenerative diseases, has closed a $3m financing. Backers include Yissum Research Develop... |
| Exithera raising $9M, develops pill as next-gen anti-stroke medication | Exithera Pharmaceuticals, a player in the anti-thrombosis and stroke prevention drug space, appears to be in the midst of a $9 million Series B round, according to regulatory filings. It has raised $3 million thus far, the filings said. Las... |
Reviews 0
FAQ about Clal Biotechnology Industries
How many startups has Clal Biotechnology Industries invested in?
Clal Biotechnology Industries has 1 portfolio company on Parsers VC.
What has the press written about Clal Biotechnology Industries?
Parsers VC has collected 3 articles mentioning Clal Biotechnology Industries, among them “Avraham Pharmaceuticals Closes $3M Financing” (Nov 14, 2011) and “Exithera raising $9M, develops pill as next-gen anti-stroke medication”.
Is Clal Biotechnology Industries still active?
Yes, Clal Biotechnology Industries is active; its latest activity on Parsers VC dates from Aug 18, 2014.